Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 1,908 | 2,141 | 2,038 | 1,907 | 1,885 |
| Cost of Goods | 2,354 | 2,236 | 2,110 | 1,866 | 1,984 |
| Gross Profit | -446 | -95 | -72 | 41 | -99 |
| Operating Expenses | -374 | 17,563 | 7,331 | 8,280 | 8,079 |
| Operating Income | 282 | -17,422 | -7,293 | -7,373 | -7,194 |
| Interest Expense | 0 | 317 | 0 | 0 | 0 |
| Other Income | -221 | 0 | -311 | -350 | -379 |
| Pre-tax Income | 61 | -17,739 | -7,604 | -7,723 | -7,573 |
| Income Tax | -2 | 15 | N/A | -261 | 16 |
| Net Income Continuous | 63 | -17,754 | -7,604 | -7,462 | -7,589 |
| Net Income | $63 | $-17,754 | $-7,604 | $-7,462 | $-7,589 |
| EPS Basic Total Ops | 0.01 | -3.56 | -1.53 | -3.06 | -5.39 |
| EPS Basic Continuous Ops | 0.01 | -3.56 | -1.53 | -0.62 | -4.33 |
| EPS Diluted Total Ops | 0.01 | -3.56 | -1.53 | -3.06 | -5.39 |
| EPS Diluted Continuous Ops | 0.01 | -3.56 | -1.53 | -0.62 | -4.33 |
| EPS Diluted Before Non-Recurring Items | -1.28 | -1.23 | -1.53 | -3.72 | -5.39 |
| EBITDA(a) | $-9,970 | $-4,374 | $-5,876 | $-6,040 | $-5,734 |